• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Efficient Suppression of Natural Plasmid-Borne Gene Expression in Carbapenem-Resistant Klebsiella pneumoniae Using a Compact CRISPR Interference System.利用紧凑型 CRISPR 干扰系统高效抑制耐碳青霉烯类肺炎克雷伯菌天然质粒携带基因的表达。
Antimicrob Agents Chemother. 2022 Nov 15;66(11):e0089022. doi: 10.1128/aac.00890-22. Epub 2022 Oct 12.
2
Inhibition of the bla gene expression in Klebsiella pneumoniae by a plasmid carrying CRISPRi-Cas9 system.质粒携带 CRISPRi-Cas9 系统抑制肺炎克雷伯菌 bla 基因表达。
Gene. 2024 Jun 5;910:148332. doi: 10.1016/j.gene.2024.148332. Epub 2024 Mar 1.
3
Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections.耐碳青霉烯类肺炎克雷伯菌感染治疗期间因质粒介导的突变导致头孢他啶-阿维巴坦耐药的出现
Antimicrob Agents Chemother. 2017 Feb 23;61(3). doi: 10.1128/AAC.02097-16. Print 2017 Mar.
4
Klebsiella pneumoniae carbapenemase (KPC) in urinary infection isolates.尿路感染分离株中的肺炎克雷伯菌碳青霉烯酶(KPC)。
Arch Microbiol. 2021 May;203(4):1825-1831. doi: 10.1007/s00203-020-02161-x. Epub 2021 Jan 28.
5
Carbapenem antibiotic stress increases bla gene relative copy number and bacterial resistance levels of Klebsiella pneumoniae.碳青霉烯类抗生素压力增加肺炎克雷伯菌 bla 基因相对拷贝数和细菌耐药水平。
J Clin Lab Anal. 2022 Jul;36(7):e24519. doi: 10.1002/jcla.24519. Epub 2022 Jun 19.
6
Co-occurrence of a novel VIM-1 and FosA3-encoding multidrug-resistant plasmid and a KPC-2-encoding pKP048-like plasmid in a clinical isolate of Klebsiella pneumoniae sequence type 11.肺炎克雷伯菌 11 型临床分离株中同时存在新型 VIM-1 和 FosA3 编码的多药耐药质粒以及 KPC-2 编码的 pKP048 样质粒
Infect Genet Evol. 2020 Nov;85:104479. doi: 10.1016/j.meegid.2020.104479. Epub 2020 Jul 27.
7
Clinical carbapenem-resistant isolates simultaneously harboring , types and qnrS genes from the Kingdom of Bahrain: Resistance profile and genetic environment.来自巴林王国的同时携带 、 和 qnrS 基因的临床耐碳青霉烯 分离株:耐药谱和遗传环境。
Front Cell Infect Microbiol. 2022 Oct 11;12:1033305. doi: 10.3389/fcimb.2022.1033305. eCollection 2022.
8
Co-Occurrence of Rare ArmA-, RmtB-, and KPC-2-Encoding Multidrug-Resistant Plasmids and Hypervirulence Operon in ST11-KL47 Klebsiella pneumoniae.ST11-KL47 肺炎克雷伯菌中同时存在稀有 ArmA、RmtB 和 KPC-2 编码的多药耐药质粒和超毒力操纵子。
Microbiol Spectr. 2022 Apr 27;10(2):e0237121. doi: 10.1128/spectrum.02371-21. Epub 2022 Mar 24.
9
Emergency of the plasmid co-carrying bla and bla genes in carbapenem-resistant hypervirulent Klebsiella pneumoniae.碳青霉烯类耐药高毒力肺炎克雷伯菌中同时携带 bla 和 bla 基因的质粒的紧急情况。
J Glob Antimicrob Resist. 2024 Mar;36:26-32. doi: 10.1016/j.jgar.2023.11.008. Epub 2023 Nov 30.
10
Microbial infection pattern, pathogenic features and resistance mechanism of carbapenem-resistant Gram negative bacilli during long-term hospitalization.长期住院患者中碳青霉烯类耐药革兰阴性杆菌的微生物感染模式、致病特征和耐药机制。
Microb Pathog. 2018 Apr;117:356-360. doi: 10.1016/j.micpath.2018.02.025. Epub 2018 Feb 13.

引用本文的文献

1
New frontiers in CRISPR: Addressing antimicrobial resistance with Cas9, Cas12, Cas13, and Cas14.CRISPR的新前沿:利用Cas9、Cas12、Cas13和Cas14应对抗菌耐药性
Heliyon. 2025 Jan 18;11(2):e42013. doi: 10.1016/j.heliyon.2025.e42013. eCollection 2025 Jan 30.
2
Harnessing CRISPR interference to resensitize laboratory strains and clinical isolates to last resort antibiotics.利用CRISPR干扰使实验室菌株和临床分离株对最后手段抗生素重新敏感。
Sci Rep. 2025 Jan 2;15(1):261. doi: 10.1038/s41598-024-81989-5.
3
Blunted blades: new CRISPR-derived technologies to dissect microbial multi-drug resistance and biofilm formation.钝刀片:用于剖析微生物多重耐药性和生物膜形成的新型CRISPR衍生技术。
mSphere. 2024 Apr 23;9(4):e0064223. doi: 10.1128/msphere.00642-23. Epub 2024 Mar 21.
4
Application of CRISPR-Cas system in the diagnosis and therapy of ESKAPE infections.CRISPR-Cas 系统在 ESKAPE 感染的诊断和治疗中的应用。
Front Cell Infect Microbiol. 2023 Aug 17;13:1223696. doi: 10.3389/fcimb.2023.1223696. eCollection 2023.
5
CRISPR-Based Gene Editing in to Combat Antimicrobial Resistance.基于CRISPR的基因编辑用于对抗抗菌药物耐药性。
Pharmaceuticals (Basel). 2023 Jun 23;16(7):920. doi: 10.3390/ph16070920.
6
CRISPR-Cas-Based Antimicrobials: Design, Challenges, and Bacterial Mechanisms of Resistance.基于 CRISPR-Cas 的抗菌剂:设计、挑战和细菌耐药机制。
ACS Infect Dis. 2023 Jul 14;9(7):1283-1302. doi: 10.1021/acsinfecdis.2c00649. Epub 2023 Jun 22.

本文引用的文献

1
The Role of the Two-Component QseBC Signaling System in Biofilm Formation and Virulence of Hypervirulent ATCC43816.双组分QseBC信号系统在高毒力ATCC43816生物膜形成和毒力中的作用
Front Microbiol. 2022 Apr 6;13:817494. doi: 10.3389/fmicb.2022.817494. eCollection 2022.
2
IS Veers Genomic Plasticity and Genetic Rearrangement toward Carbapenem Hyperresistance under Sublethal Antibiotics.IS 菌的基因组可塑性和遗传重排使其对亚致死浓度抗生素产生超耐药性。
mBio. 2021 Feb 22;13(1):e0334021. doi: 10.1128/mbio.03340-21. Epub 2022 Feb 8.
3
Resistance evolution of hypervirulent carbapenem-resistant ST11 during treatment with tigecycline and polymyxin.碳青霉烯类药物耐药超毒力 ST11 在替加环素和黏菌素治疗过程中的耐药演变。
Emerg Microbes Infect. 2021 Dec;10(1):1129-1136. doi: 10.1080/22221751.2021.1937327.
4
Switching metabolic flux by engineering tryptophan operon-assisted CRISPR interference system in Klebsiella pneumoniae.通过工程色氨酸操纵子辅助 CRISPR 干扰系统在肺炎克雷伯氏菌中切换代谢通量。
Metab Eng. 2021 May;65:30-41. doi: 10.1016/j.ymben.2021.03.001. Epub 2021 Mar 5.
5
Exploration of Bacterial Bottlenecks and Streptococcus pneumoniae Pathogenesis by CRISPRi-Seq.通过 CRISPRi-Seq 探索细菌瓶颈和肺炎链球菌发病机制。
Cell Host Microbe. 2021 Jan 13;29(1):107-120.e6. doi: 10.1016/j.chom.2020.10.001. Epub 2020 Oct 28.
6
The Small Protein RmpD Drives Hypermucoviscosity in Klebsiella pneumoniae.小分子蛋白 RmpD 驱动肺炎克雷伯菌的高黏液性。
mBio. 2020 Sep 22;11(5):e01750-20. doi: 10.1128/mBio.01750-20.
7
CRISPR-Cas9-Mediated Carbapenemase Gene and Plasmid Curing in Carbapenem-Resistant .CRISPR-Cas9 介导的碳青霉烯酶基因和质粒在碳青霉烯类耐药菌中的消除。
Antimicrob Agents Chemother. 2020 Aug 20;64(9). doi: 10.1128/AAC.00843-20.
8
Epidemiology of carbapenemase-producing Klebsiella pneumoniae in northern Portugal: Predominance of KPC-2 and OXA-48.葡萄牙北部产碳青霉烯酶肺炎克雷伯菌的流行病学:以 KPC-2 和 OXA-48 为主。
J Glob Antimicrob Resist. 2020 Sep;22:349-353. doi: 10.1016/j.jgar.2020.04.007. Epub 2020 Apr 27.
9
Adaptive evolution of virulence and persistence in carbapenem-resistant Klebsiella pneumoniae.耐碳青霉烯类肺炎克雷伯菌毒力和持久性的适应性进化。
Nat Med. 2020 May;26(5):705-711. doi: 10.1038/s41591-020-0825-4. Epub 2020 Apr 13.
10
The Colonization of Carbapenem-Resistant Klebsiella pneumoniae: Epidemiology, Resistance Mechanisms, and Risk Factors in Patients Admitted to Intensive Care Units in China.耐碳青霉烯类肺炎克雷伯菌的定植:中国重症监护病房患者的流行病学、耐药机制和危险因素。
J Infect Dis. 2020 Mar 16;221(Suppl 2):S206-S214. doi: 10.1093/infdis/jiz622.

利用紧凑型 CRISPR 干扰系统高效抑制耐碳青霉烯类肺炎克雷伯菌天然质粒携带基因的表达。

Efficient Suppression of Natural Plasmid-Borne Gene Expression in Carbapenem-Resistant Klebsiella pneumoniae Using a Compact CRISPR Interference System.

机构信息

State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.

College of Life Science, University of Chinese Academy of Sciences, Beijing, China.

出版信息

Antimicrob Agents Chemother. 2022 Nov 15;66(11):e0089022. doi: 10.1128/aac.00890-22. Epub 2022 Oct 12.

DOI:10.1128/aac.00890-22
PMID:36222525
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9664848/
Abstract

There is an urgent need for efficient tools for genetic manipulation to assess plasmid function in clinical drug-resistant bacterial strains. To address this need, we developed an all-in-one CRISPR interference (CRISPRi) system that easily inhibited the gene expression of a natural multidrug-resistant plasmid in an sequence type 23 (ST23) Klebsiella pneumoniae isolate. We established an integrative CRISPRi system plasmid, pdCas9gRNA, harboring a gene and a single guide RNA (sgRNA) unit under the control of anhydrotetracycline-induced and J23119 promoters, respectively, using a one-step cloning method. This system can repress the single resistance gene , with a >1,000-fold reduction in the meropenem MIC, or simultaneously silence the resistance genes and , with a 16-fold and 8-fold respective reduction in the meropenem and aztreonam MIC on a large natural multidrug-resistant pNK01067-NDM-1 plasmid in an ST23 K. pneumoniae isolate. Furthermore, an sgRNA targeting the promoter region can silence the entire operon, confirming the existence of the operon. We also used this tool to knock down the multicopy resistance gene in pathogenic Escherichia coli, increasing the susceptibility to meropenem. In a word, the all-in-one CRISPRi system can be used for efficient interrogation of indigenous plasmid-borne gene functions, providing a rapid, easy genetic manipulation tool for clinical K. pneumoniae isolates.

摘要

目前迫切需要有效的基因操作工具来评估临床耐药细菌菌株中质粒的功能。为了满足这一需求,我们开发了一种即插即用的 CRISPR 干扰(CRISPRi)系统,该系统可轻松抑制 23 型(ST23)肺炎克雷伯菌分离株中天然多药耐药质粒的基因表达。我们使用一步克隆法建立了一个整合的 CRISPRi 系统质粒 pdCas9gRNA,该质粒包含一个基因和一个单指导 RNA(sgRNA)单元,分别受脱水四环素诱导和 J23119 启动子的控制。该系统可以抑制单个耐药基因 ,使美罗培南 MIC 降低 1000 倍以上,或同时沉默耐药基因 和 ,使 ST23 肺炎克雷伯菌分离株中天然多药耐药 pNK01067-NDM-1 质粒的美罗培南和氨曲南 MIC 分别降低 16 倍和 8 倍。此外,靶向 启动子区域的 sgRNA 可沉默整个 操纵子,证实了操纵子的存在。我们还使用该工具敲低了致病性大肠杆菌中的多拷贝耐药基因 ,增加了对美罗培南的敏感性。总之,这种即插即用的 CRISPRi 系统可用于高效探究本土质粒携带基因的功能,为临床肺炎克雷伯菌分离株提供了一种快速、简便的遗传操作工具。